BioPlus Co Ltd
KOSDAQ:099430
BioPlus Co Ltd
Intangible Assets
BioPlus Co Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Intangible Assets
₩4.7B
|
CAGR 3-Years
38%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Intangible Assets
₩5.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-3%
|
|
|
SD Biosensor Inc
KRX:137310
|
Intangible Assets
₩723.1B
|
CAGR 3-Years
543%
|
CAGR 5-Years
327%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Intangible Assets
₩286.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
72%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Intangible Assets
₩3.6B
|
CAGR 3-Years
28%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Intangible Assets
₩1.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
BioPlus Co Ltd
Glance View
BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.
See Also
What is BioPlus Co Ltd's Intangible Assets?
Intangible Assets
4.7B
KRW
Based on the financial report for Dec 31, 2024, BioPlus Co Ltd's Intangible Assets amounts to 4.7B KRW.
What is BioPlus Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
43%
Over the last year, the Intangible Assets growth was 18%. The average annual Intangible Assets growth rates for BioPlus Co Ltd have been 38% over the past three years , 43% over the past five years .
